These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18021517)

  • 1. Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
    Mukhtyar C; Luqmani R
    Clin Exp Rheumatol; 2007; 25(6 Suppl 47):120-9. PubMed ID: 18021517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
    Hellmich B; Flossmann O; Gross WL; Bacon P; Cohen-Tervaert JW; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott DG; Witter J; Yazici H; Luqmani RA
    Ann Rheum Dis; 2007 May; 66(5):605-17. PubMed ID: 17170053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and management of small vessel vasculitides].
    Pettersson T; Karjalainen A
    Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: Progress of treatment in ANCA-associated vasculitis.
    Jayne D
    Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
    Merkel PA; Seo P; Aries P; Neogi T; Villa-Forte A; Boers M; Cuthbertson D; Felson DT; Hellmich B; Hoffman GS; Jayne DR; Kallenberg CG; Krischer J; Mahr A; Matteson EL; Specks U; Luqmani R; Stone J; ;
    J Rheumatol; 2005 Dec; 32(12):2488-95. PubMed ID: 16331794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
    Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
    Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
    Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uptodate in the management and treatment of ANCA-associated vasculitis].
    Belaconi IN; Toma CL; Bogdan MA
    Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal vasculitis and glomerulonephritis with anti-neutrophil cytoplasmic antibody positivity].
    Tesar V; Rychlík I; Bartůnková J; Stejsakalová A; Zabka J; Janatková I; Fucíková T; Becvár R
    Cas Lek Cesk; 1996 Jan; 135(3):79-83. PubMed ID: 8625374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based management of ANCA vasculitis.
    Carruthers D; Sherlock J
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ANCA-associated systemic vasculitis.
    Belmont HM
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state of biologicals in the management of systemic vasculitis.
    Lamprecht P; Till A; Steinmann J; Aries PM; Gross WL
    Ann N Y Acad Sci; 2007 Sep; 1110():261-70. PubMed ID: 17911441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis.
    Jones RB
    Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.
    Brijker F; Magee CC; Tervaert JW; O'Neill S; Walshe JJ
    Clin Nephrol; 1999 Dec; 52(6):344-51. PubMed ID: 10604641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.